LumiraDx Lab Analysis Confirms its COVID-19 Antigen Test Detects the Omicron Variant
Results from ongoing testing and monitoring of COVID-19 variants shows the rapid microfluidic test detects Omicron at a comparable sensitivity to other variants LONDON, Jan. 14, 2022 /PRNewswire/ -- LumiraDx (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced that results from ongoing testing and monitoring of COVID-19 variants show its...
EW Nutrition showcases innovative solutions at International Dairy Week 2022
SINGAPORE, Jan. 14, 2022 /PRNewswire/ -- EW Nutrition will participate in Australia's International Dairy Week (IDW) in Tatura, Victoria, from January 16 to 20, 2022. Visitors will learn about innovative solutions for ruminant nutrition. Located at Site 37, EW Nutrition also invites attendees to explore topics such as toxin risk management and respiratory issues. "We are excited to be...
Everest Medicines Enters into a Global Licensing Agreement to Develop and Commercialize Singapore’s Experimental Drug Development Centre’s 3CL Protease Inhibitors as Potentially Best-in-Class COVID-19 Oral Antiviral Treatments Worldwide
SHANGHAI, Jan. 14, 2022 /PRNewswire/ -- Everest Medicines(HKEX 1952.HK, "Everest", or the "Company"), and Singapore's Experimental Drug Development Centre ("EDDC") today announced a global licensing agreement under which Everest will obtain exclusive worldwide rights to develop, manufacture and commercialize EDDC's series of viral 3C-like ("3CL") protease inhibitors as potentially best-in-class COVID-19 oral antiviral treatments. EDDC is Singapore's national platform...
Dr. Luciana Young Named Vice Chair of Inteleos Board of Directors
Pediatric cardiologist, researcher, and professor extends service, gains new responsibility ROCKVILLE, Md., Jan. 13, 2022 /PRNewswire/ -- Inteleos™, a non-profit global healthcare certification organization, today named pediatric cardiologist Dr. Luciana Young, MD, FASE, FAHA, FACC, as vice chair of its Board of Directors through 2023. An Inteleos volunteer since 2006 and board member since 2012, Dr. Young will work closely...
Leading E-commerce Logistics and Fulfillment Brand NextSmartShip Partners with B2B Medical E-commerce Giant LyncMed
SHENZHEN, China, Jan. 13, 2022 /PRNewswire/ -- NextSmartShip, a world-leading fulfillment service provider for global e-commerce sellers, signed a strategic partnership agreement with LyncMed, a major global e-commerce platform for medical instruments. Under this partnership, NextSmartShip will empower LyncMed during its global expansion with industry-leading logistics and fulfillment expertise and the next-gen proprietary SaaS platform – Fulfillship. Global e-commerce...
United Imaging Announces Construction of a World-leading Intelligent R&D and Manufacturing Complex with an Investment of More Than USD 490 million
SHANGHAI, Jan. 13, 2022 /PRNewswire/ -- Recently, the construction of United Imaging's brand new Manufacturing and R&D base of operations officially kicked off. With a total investment of USD 490 million and a planned footprint of about 420,000 square meters, the company is creating a modern campus that integrates functions such as technology research and development, intelligent manufacturing,...
Ascletis Announces First Patient Dosed in the Phase II Clinical Trial of FASN Inhibitor ASC40 for Treatment of Moderate to Severe Acne
HANGZHOU and SHAOXING, China, Jan. 13, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces the dosing of the first patient in the Phase II clinical trial of ASC40 for moderate to severe acne. ASC40 is an oral, selective inhibitor of fatty acid synthase (FASN), a key enzyme which regulates de novo lipogenesis. Human sebum production requires de...
LYNC2M Sets to Deliver 41.67 Million Pairs of Nitrile Gloves in February for Its Largest Order in 2022 to Date
LONDON, Jan. 13, 2022 /PRNewswire/ -- Leading Chinese consumer to manufacturer (C2M) medical products supply chain platform, LYNC2M Medical Technology (Beijing) Co., Ltd. ("LYNC2M"), plans to deliver in February of its first batch of 41.67 million sets of nitrile gloves to UK for a public health service purposed order, which requesting a total of one billion nitrile gloves in...
Accuredit Therapeutics and N1 Life Form a Joint Venture Named ‘Napoltec’, Dedicated to the Development of Therapeutic Drug Delivery Systems and Pressing Ahead Clinical Translation
SUZHOU, China, Jan. 13, 2022 /PRNewswire/ -- Accuredit Therapeutics (Suzhou) Co., Ltd. (hereinafter referred to as Accuredit), an emerging company based on new generations of safe and highly targeted gene editing therapies, and N1 Life, a biotech company focused on developing cutting-edge drug delivery technologies and clinical products, announced a strategic...
NeuroAiD(TM)II holds promise as a safe add-on therapy to standard Alzheimer Disease symptomatic treatments and may have a disease modifying effect by delaying disease progression
SINGAPORE, Jan. 13, 2022 /PRNewswire/ -- Moleac is pleased to announce the release of the ATHENE study results, published in the Journal of the American Medical Director Association (JAMDA)1. Alzheimer's Disease (AD) and other dementias cause a heavy economic and public healthcare burden worldwide. The number of people living with dementia continues to increase mainly due to population...
